<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01555502</url>
  </required_header>
  <id_info>
    <org_study_id>HRQOL VATS lobectomy</org_study_id>
    <nct_id>NCT01555502</nct_id>
  </id_info>
  <brief_title>Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alberta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johnson &amp; Johnson</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alberta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the effect of post operative complications on the health related quality of life&#xD;
      (HRQOL) after Video Assisted Thoracoscopic Surgery (VATS) for Non-Small Cell Lung Cancer&#xD;
      (NSCLC).&#xD;
&#xD;
      The HRQOL of patients with early stage NSCLC will be assessed at baseline (before surgery)&#xD;
      using 3 different reliable and valid HRQOL questionnaire (SF-36, EQ-5D and QLQ30/13), then at&#xD;
      regular intervals in the early post-operative period (2,4,8 and 12 weeks) the HRQOL will be&#xD;
      assessed using the same questionnaires to determine the difference between patients with&#xD;
      low/no post operative complications to those with high grade post-operative complications.&#xD;
&#xD;
      Post operative complications will be assess while the patients in the hospital on a daily&#xD;
      basis using the Clavien classification system for surgical complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health related Quality of life</measure>
    <time_frame>Change in health related quality of life at 2 weeks. Change of Health Related Quality of Life at 4 weeks. Change in Health Related Quality of Life at 8 weeks. Change in Health Related Quality of Life at 12 weeks.</time_frame>
    <description>Health Related Quality of Life will be assessed using the SF-36, EQ-5D and QLQ30/13 questionnaires.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Operable Early Stage NSCLC by the VATS Approach</condition>
  <arm_group>
    <arm_group_label>low complications</arm_group_label>
    <description>Patients who had VATS lung resection for NSCLC, and have no or low grade (grade 1 and 2) post operative complications based on the Clavien classification system.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High complications</arm_group_label>
    <description>Patients who had VATS lung resection for NSCLC, and have no or high grade (grade 3 and 4) post operative complications based on the Clavien classification system.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with operable early stage NSCLC by the VATS approach who are referred to the&#xD;
        Thoracic surgery Center in Edmonton, Alberta, Canada.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (more than 18 years)&#xD;
&#xD;
          -  early stage NSCLC&#xD;
&#xD;
          -  speak English&#xD;
&#xD;
          -  No hearing/Speaking difficulties&#xD;
&#xD;
          -  Able to walk without assistance&#xD;
&#xD;
          -  Surgery via the VATS approach&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 18 years old&#xD;
&#xD;
          -  Metastatic disease to the lung&#xD;
&#xD;
          -  Benign Lung disease&#xD;
&#xD;
          -  Advanced NSCLC&#xD;
&#xD;
          -  Small Cell Lung Cancer&#xD;
&#xD;
          -  Non English speakers&#xD;
&#xD;
          -  Walking/Hearing/Speaking difficulties&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <study_first_submitted>March 7, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>May 26, 2015</last_update_submitted>
  <last_update_submitted_qc>May 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

